COVID-19 has rapidly become a major health emergency worldwide. Patients with IBD are at increased risk of infection, especially when they have active disease and are taking immunosuppressive therapy. The characteristics and outcomes of COVID-19 in patients with IBD remain unclear.

Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study

Danese, Silvio;Armuzzi, Alessandro;Fiorino, Gionata
2020-01-01

Abstract

COVID-19 has rapidly become a major health emergency worldwide. Patients with IBD are at increased risk of infection, especially when they have active disease and are taking immunosuppressive therapy. The characteristics and outcomes of COVID-19 in patients with IBD remain unclear.
2020
IBD
epidemiology
Age Factors
Betacoronavirus
COVID-19
Comorbidity
Female
Hospitalization
Humans
Immunosuppressive Agents
Italy
Male
Middle Aged
Outcome and Process Assessment, Health Care
Patient Acuity
Prospective Studies
Risk Factors
SARS-CoV-2
Coronavirus Infections
Inflammatory Bowel Diseases
Pandemics
Patient Care Management
Pneumonia, Viral
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/56835
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact